PP

Prachi Parth Auradkar

Active Director Whole-Time Director DIN 11157347
DIN 11157347 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Prachi Parth Auradkar

Data last updated:

Prachi Parth Auradkar is a Whole-Time Director at Pharmalux-D Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11157347
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 17 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director17 Jun 20252025Active

Board colleagues of Prachi Parth Auradkar

NameDINCompanyDesignation
Dhananjay Dattatraya Kulkarni03422428Pharmalux-D Pharmaceuticals Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Pharmalux-D Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prachi Parth Auradkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prachi Parth Auradkar

Prachi Parth Auradkar currently holds 1 directorship: Pharmalux-D Pharmaceuticals Private Limited (Whole-Time Director, since 17 Jun 2025).

Prachi Parth Auradkar was first appointed on 17 Jun 2025 as Whole-Time Director at Pharmalux-D Pharmaceuticals Private Limited.

The current boards of Prachi Parth Auradkar's companies include Dhananjay Dattatraya Kulkarni (Pharmalux-D Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available